Nectero Therapeutics (also operating as Nectero Medical) is a clinical-stage biopharmaceutical company developing a novel, minimally invasive treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA). - View it on GitHub